View of Use of anti-citrullinated peptide (Anti–CCP) antibodies in distinguishing patients with systemic lupus erythematosus and rheumatoid arthritis

Return to Article Details Use of anti-citrullinated peptide (Anti–CCP) antibodies in distinguishing patients with systemic lupus erythematosus and rheumatoid arthritis Download Download PDF